M. Maral Mouradian, MD

Distinguished Professor, Vice Chancellor for Faculty Development at Rutgers Biomedical and Health Sciences, and Chief of Movement Disorders

Department(s) Neurology

Bio

Dr. Mouradian is the William Dow Lovett Endowed Chair for Parkinson's Research, the founding director of the Institute for Neurological Therapeutics, the Vice Chancellor for Faculty Development at Rutgers Biomedical and Health Sciences, the chief of the Division of Movement Disorders, and the director of the American Parkinson Disease Association Center for Advanced Research at Robert Wood Johnson Medical School.

Dr. Mouradian is an internationally recognized physician scientist in the understanding and treatment of Parkinson’s disease. She trained in neurology at the University of Cincinnati Medical Center followed by further study in movement disorders, neuropharmacology and molecular neurobiology at the US National Institutes of Health (NIH) where she worked with the Nobel Laureate Marshall Nirenberg. Prior to joining Rutgers, Dr. Mouradian led the Genetic Pharmacology research program of the National Institute for Neurological Disorders and Stroke at the NIH.

Her career focus has been to elucidate the molecular pathogenesis of Parkinson’s disease (PD) and its treatment complications, and to develop improved and novel therapies both for disease modification and better symptom control. Her seminal contributions have provided the rationale for the development of continuous therapeutic modalities for PD such as pump, skin patch, and controlled release formulations of oral drugs. To date, she has authored over 200 scholarly publications, edited two books on Parkinson’s disease, and holds several patents. Her research is funded by the NIH, the Michael J. Fox Foundation for Parkinson’s Research, the American Parkinson Disease Association and other foundations. She chairs the Scientific Review Committee of the Parkinson Study Group and serves on the Scientific Advisory Board of the American Parkinson Disease Association and the Board of Directors of the American Society for Experimental Neurotherapeutics. In addition, she is the Editor-in-Chief of the journal Neurotherapeutics.  She the recipient of several awards including the NIH award of Merit, the Board of Trustees Award for Excellence in Research and the Daniel Gorenstein Memorial Award both from Rutgers University, the Honorary Alumni Award from Robert Wood Johnson Medical School, and the Outstanding Medical Research Scientist Award from the Edward J. Ill Excellence in Medicine Awards. She is a member of the Association of American Physicians and a Fellow of the American Association for the Advancement of Science.